Literature DB >> 2485082

Uveitopathogenic sites in bovine S-antigen.

V K Singh1, L A Donoso, K Yamaki, T Shinohara.   

Abstract

Experimental autoimmune uveitis (EAU) was observed in Hartley guinea pigs following immunization with high doses (200 micrograms) of four synthetic peptides designated peptide 3, K, N and M which correspond to amino acid positions 221-240, 241-260, 281-302, and 303 to 320 respectively in bovine S-antigen. Histopathologically, a moderate inflammatory response involving the uveal tract and retina was observed using peptide N and peptide M as immunogens, whereas peptide 3 and peptide K caused only a mild inflammatory response with very few inflammatory cells in the retina. In contrast, animals with EAU showed an associated pinealitis (EAP) characterized by an extensive lymphocytic infiltration of the central and subcapsular areas of the pineal gland. Lymph node cells of guinea pigs immunized with peptide 3, peptide K, peptide N or peptide M showed strong in vitro proliferative responses against the respective immunizing peptide as measured by [3H] thymidine uptake. The results suggest that under appropriate experimental conditions S-antigen may contain multiple pathogenic sites. The relevance of these studies in the pathogenesis of EAU is discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2485082     DOI: 10.3109/08916938909099015

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  3 in total

Review 1.  Cytokines in posterior uveitis: an update.

Authors:  V K Singh; G Rai
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

2.  Cellular immune responses of patients with juvenile chronic arthritis to retinal antigens and their synthetic peptides.

Authors:  D Gupta; V K Singh; J Rajasingh; T Shinohara; R Misra; S S Agarwal
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

3.  Cellular immune response of patients with uveitis to peptide M, a retinal S-antigen fragment.

Authors:  S Nityanand; V K Singh; T Shinohara; A K Paul; V Singh; P K Agarwal; S S Agarwal
Journal:  J Clin Immunol       Date:  1993-09       Impact factor: 8.317

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.